Sign in
The ADPRT V762A genetic variant contributes to prostate cancer susceptibility and deficient enzyme function
Journal article   Open access  Peer reviewed

The ADPRT V762A genetic variant contributes to prostate cancer susceptibility and deficient enzyme function

Kristin L LOCKETT, M. Craig HALL, JIANFENG JIANFENG XU, S. Lilly ZHENG, Marianne BERWICK, Shu-Chun CHUANG, Peter E CLARK, Scott D CRAMER, Kurt LOHMAN and Jennifer J HU
Cancer research (Chicago, Ill.), Vol.64(17), pp.6344-6348
2004
PMID: 15342424

Abstract

Biological and medical sciences Medical sciences Antineoplastic agents Pharmacology. Drug treatments Tumors
url
https://doi.org/10.1158/0008-5472.CAN-04-0338View
Published (Version of record) Open

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.152 Molecular & Cell Biology - DNA Damage
1.152.257 DSBs
Web Of Science research areas
Oncology
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details